4,585 trials (keyword fallback)
Heart Failure · Atrial Fibrillation
Primary: Composite of All-cause Mortality and Heart Failure Events — 50; 64 Participants
Atrial Fibrillation · Mitral Valve Insufficiency · Mitral Valve Stenosis
Primary: Freedom From Atrial Fibrillation — 31.1; 61.8 percentage of patients
Heart Rate and Rhythm Disorders
Primary: Percent of Patients Reaching Target HR<100bpm Within 30 Minutes — 46.4; 95.8 percentage of participants — p=.0001
Permanent Atrial Fibrillation
Primary: Patient Reported Quality of Life (SF-36) — 29.7; 31.9 score on a scale
Atrial Fibrillation
Primary: Gaps Days Between Prescription Refills for Dabigatran, Rivaroxaban, and Apixaban — 43; 51; 41; -5 days
Coronary Artery Bypass Grafting · Postoperative Atrial Fibrilation · Stroke
Primary: Number of Participants With Strokes — 0; 0 participants — p=1.0
Atrial Fibrillation · Arrhythmia
Primary: Number of Participants With Composite of Total Mortality, Disabling Stroke, Serious Bleeding, or Cardiac Arrest in Patients Warranting Therapy for AF. — 89; 101…
Atrial Fibrillation · Arrhythmias, Cardiac
Primary: Recurrence Rate of Atrial Arrhythmias — 8; 14; 7; 1 participants — p=0.047
Atrial Fibrillation
Primary: Proportions of Adherent, Partially Adherent, Partially Non-adherent and Completely Non-adherent Patients (NSEPh During V1) — 155; 5; 7; 33 Participants
Atrial Fibrillation
Primary: Success of Stellate Ganglion Block — 22 Participants
Atrial Fibrillation
Primary: Arrhythmia Burden — 7; 18; 18; 5 Participants
Paroxysmal Atrial Fibrillation
Primary: Acute Procedural Success (APS) — 160 participants
Atrial Fibrillation
Primary: Number of Participants Who Experienced Net Adverse Clinical Events (Adjudicated Data) Based on ISTH Criteria in Participants Taking Edoxaban vs VKA — 170; 157…
Atrial Fibrillation
Primary: Procedure Time (Minutes) — 128.7; 137.8 minutes
Atrial Fibrillation · Atrial Flutter
Primary: Changes in Discordant Antithrombotic Therapy — 291; 335; 277; 329 participants — p=0.02